Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
290.81
+4.90 (1.71%)
Oct 21, 2025, 12:47 PM EDT - Market open
Veeva Systems Market Cap
Veeva Systems has a market cap or net worth of $47.67 billion as of October 21, 2025.
Market Cap
47.67B
Enterprise Value
41.11B
1-Year Change
n/a
Ranking
Category
Stock Price
$290.81
Market Cap Chart
Since September 15, 2025, Veeva Systems's market cap has increased from $45.28B to $47.67B, an increase of 5.26%. That is a compound annual growth rate of 70.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 46.86B | 37.29% |
| Dec 31, 2024 | 34.13B | 10.11% |
| Dec 29, 2023 | 31.00B | 23.38% |
| Dec 30, 2022 | 25.13B | -36.04% |
| Dec 31, 2021 | 39.28B | -4.74% |
| Dec 31, 2020 | 41.24B | 97.30% |
| Dec 31, 2019 | 20.90B | 61.04% |
| Dec 31, 2018 | 12.98B | 66.10% |
| Dec 29, 2017 | 7.81B | 39.96% |
| Dec 30, 2016 | 5.58B | 45.50% |
| Dec 31, 2015 | 3.84B | 11.25% |
| Dec 31, 2014 | 3.45B | -13.77% |
| Dec 31, 2013 | 4.00B | -11.95% |
| Oct 16, 2013 | 4.54B | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |